Centese develops cardiothoracic post-operative medical equipment for post-operative surgical care and patient monitoring.
Centese has raised $250K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2026.
Centese's investors include National Science Foundation, Invest Nebraska, MedTech Venture Partners, New York Angels.
Centese is headquartered in Omaha, United States.
Centese develops cardiothoracic post-operative medical equipment for post-operative surgical care and patient monitoring.
Centese is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Centese — Funding & Investors." VCBacked, May 26, 2026, https://www.vcbacked.co/company/centese. Accessed July 20, 2026.
VCBacked. (2026). Centese — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/centese
{{cite web |title=Centese — Funding & Investors |url=https://www.vcbacked.co/company/centese |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated